skinny.

Latest / Booking Health

Dendritic Cell Immunotherapy for Non-Small Cell Lung Cancer

Non-small cell lung cancer affects 85% of lung cancer patients, with stage III-IV cases having less than 5% five-year survival rates. While traditional treatments help only 30% of selected patients, innovative dendritic cell immunotherapy shows 50-65% effectiveness rates in clinical studies. These "immune system generals" train your body to fight cancer cells, offering hope where conventional therapies fall short. German clinics report complete recoveries with patients remaining cancer-free for over five years.

🎙 Voiced by AI

📩 Please send your request using the following link…

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.